Comparison of One-Tier and Two-Tier Newborn Screening Metrics for Congenital Adrenal Hyperplasia
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Newborn screening (NBS) for the classic forms of congenital adrenal hyperplasia (CAH) is mandated in all states in the United States. Compared with other NBS disorders, the false-positive rate (FPR) of CAH screening remains high and has not been significantly improved by adjusting 17α-hydroxyprogesterone cutoff values for birth weight and/or gestational age. Minnesota was the first state to initiate, and only 1 of 4 states currently performing, second-tier steroid profiling for CAH. False-negative rates (FNRs) for CAH are not well known. METHODS: This is a population-based study of all Minnesota infants (769,834) born 1999-2009, grouped by screening protocol (one-tier with repeat screen, January 1999 to May 2004; two-tier with second-tier steroid profiling, June 2004 to December 2009). FPR, FNR, and positive predictive value (PPV) were calculated per infant, rather than per sample, and compared between protocols. RESULTS: Overall, 15 false-negatives (4 salt-wasting, 11 simple-virilizing) and 45 true-positives were identified from 1999 to 2009. With two-tier screening, FNR was 32%, FPR increased to 0.065%, and PPV decreased to 8%, but these changes were not statistically significant. Second-tier steroid profiling obviated repeat screens of borderline results (355 per year average). CONCLUSIONS: In comparing the 2 screening protocols, the FPR of CAH NBS remains high, the PPV remains low, and false-negatives occur more frequently than has been reported. Physicians should be cautioned that a negative NBS does not necessarily rule out classic CAH; therefore, any patient for whom there is clinical concern for CAH should receive immediate diagnostic testing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Screening a second sample several days later also improves both sensitivity and positive predictive value (47,61,68).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [68]
In the citing paper
“This strategy was used in actual practice as the second-tier screen in Minnesota for 3 years (204,000 births) and improved the positive predictive value of the CAH screen (82), but subsequent reports from the same center suggested that this approach was inferior to testing a second sample by routine immunoassay (67,68).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [68]
Citations
Cites
Interval Estimation for a Binomial Proportion
Brown, L. D., Cai, T. T., & DasGupta, A. (2001) · Statistical Science · doi:10.1214/ss/1009213286 · Cited by 3,538
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Waisbren, S. E. (2003) · JAMA · doi:10.1001/jama.290.19.2564 · Cited by 360
Therrell, B. L., Berenbaum, S. A., Manter-Kapanke, V., Simmank, J., Korman, K., Prentice, L., Gonzalez, J., & Gunn, S. (1998) · Pediatrics · doi:10.1542/peds.101.4.583 · Cited by 344
PANG, S., HOTCHKISS, J., DRASH, A. L., LEVINE, L. S., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-5-1003 · Cited by 293
Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result
Gurian, E. A., Kinnamon, D. D., Henry, J. J., & Waisbren, S. E. (2006) · Pediatrics · doi:10.1542/peds.2005-2294 · Cited by 223
Lacey, J. M., Minutti, C. Z., Magera, M. J., Tauscher, A. L., Casetta, B., McCann, M., Lymp, J., Hahn, S. H., Rinaldo, P., & Matern, D. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.027193 · Cited by 216
Self-citationWong, T., Shackleton, C. H., Covey, T. R., & Ellis, G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1830 · Cited by 159
Allen, D. B., Hoffman, G. L., Fitzpatrick, P., Laessig, R., Maby, S., & Slyper, A. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70321-4 · Cited by 153
Thilén, A., Nordenström, A., Hagenfeldt, L., von Döbeln, U., Guthenberg, C., & Larsson, A. (1998) · PEDIATRICS · doi:10.1542/peds.101.4.e11 · Cited by 151
Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism
Larson, C. A., Hermos, R. J., Delaney, A., Daley, D., & Mitchell, M. L. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00332-9 · Cited by 130
Nordenström, A., Wedell, A., Hagenfeldt, L., Marcus, C., & Larsson, A. (2001) · Pediatrics · doi:10.1542/peds.108.4.e68 · Cited by 93
Newborn Screening for Congenital Adrenal Hyperplasia inthe Netherlands
Van der Kamp, H. J., Noordam, K., Elvers, B., Van Baarle, M., Otten, B. J., & Verkerk, P. H. (2001) · PEDIATRICS · doi:10.1542/peds.108.6.1320 · Cited by 86
Maturity of the Adrenal Cortex in Very Preterm Infants Is Related to Gestational Age
Bolt, R. J., van Weissenbruch, M. M., Popp‐Snijders, C., Sweep, F. C. G. J., Lafeber, H. N., & de Waal, H. A. D. (2002) · Pediatric Research · doi:10.1203/00006450-200209000-00017 · Cited by 76
Doerr, H. G., Sippell, W. G., VERSMOLD, H. T., BIDLINGMAIER, F., & Knorr, D. (1988) · Pediatric Research · doi:10.1203/00006450-198805000-00018 · Cited by 70
Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia
Votava, F., Török, D., Kovács, J., Möslinger, D., Baumgartner-Parzer, S. M., Sólyom, J., Pribilincová, Z., Battelino, T., Lebl, J., Frisch, H., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01929 · Cited by 64
Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls
Varness, T. S., Allen, D. B., & Hoffman, G. L. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.035 · Cited by 61
Gatelais, F., Berthelot, J., Beringue, F., Descamps, P., Bonneau, D., Limal, J.-M., & Coutant, R. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000142733.50918.6e · Cited by 60
Weissbourd, R. (1995) · Cited by 52
Neonatal Screening Program for Congenital Adrenal Hyperplasia: Adjustments to the Recall Protocol
Gruñeiro-Papendieck, L., Prieto, L., Chiesa, A., Bengolea, S., Bossi, G., & Bergadá, C. (2001) · Hormone Research in Paediatrics · doi:10.1159/000050012 · Cited by 50
Consultation with the Specialist: Table.
Pearson, S. R., & Boyce, W. T. (2004) · Pediatrics in Review · doi:10.1542/pir.25-10-345 · Cited by 42
Wedell, A. (1998) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1998.11.5.581 · Cited by 40
Tylek-Lemańska, D., Kumorowicz-Kopiec, M., & Starzyk, J. (2005) · Journal of Medical Screening · doi:10.1258/096914105775220697 · Cited by 40
Schreiner, F., Brack, C., Salzgeber, K., Vorhoff, W., Woelfle, J., & Gohlke, B. C. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0505-0 · Cited by 35
Minutolo, C., Nadra, A. D., Fernández, C., Taboas, M., Buzzalino, N., Casali, B., Belli, S., Charreau, E. H., Alba, L., & Dain, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015899 · Cited by 31
Consultation with the Specialist
Leslie, L. K., & Boyce, W. T. (1996) · Pediatrics in Review · doi:10.1542/pir.17-9-323 · Cited by 28
Sarafoglou, K., Lorentz, C. P., Otten, N., Oetting, W. S., & Grebe, S. K. G. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01694.x · Cited by 16
Self-citationGudmundsson, K., Majzoub, J. A., Bradwin, G., Mandel, S., & Rifai, N. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.6.895 · Cited by 8
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Inborn errors of metabolism and expanded newborn screening: review and update
Mak, C. M., Lee, H.-C. H., Chan, A. Y.-W., & Lam, C.-W. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847896 · Cited by 201
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Congenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 161
Expanded newborn screening by mass spectrometry: New tests, future perspectives
Ombrone, D., Giocaliere, E., Forni, G., Malvagia, S., & la Marca, G. (2015) · Mass Spectrometry Reviews · doi:10.1002/mas.21463 · Cited by 154
Metadata
- Authors
- Sarafoglou, K., Banks, K., Gaviglio, A., Hietala, A., McCann, M., & Thomas, W.
- Affiliations
- University of Minnesota (US)
- Minnesota Department of Health (US)
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2012-11-01
- Volume
- 130
- Issue
- 5
- Pages
- e1261-e1268
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2156177778
- Cited by
- 69
- References
- 29
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 9 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 5
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital adrenal hyperplasia, newborn screening, false positive rate, false negative rate, positive predictive value, 17-hydroxyprogesterone, repeat screening, salt-wasting CAH, simple virilizing CAH
- MeSH terms
- Adrenal Hyperplasia, Congenital, Clinical Protocols, Female, Humans, Infant, Newborn, Male, Retrospective Studies, Neonatal Screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.